FI
ATRS

Fosun International’s Antares Pharma, Inc. ATRS Stock Holding History

Fosun International’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-809,378
Closed -$2.57M – 314
2019
Q2 		$2.57M Buy
809,378
+217,670
+37% +$630K 0.17% 90
2019
Q1 		$1.77M Buy
591,708
+52,108
+10% +$169K 0.11% 112
2018
Q4 		$1.41M Buy
+539,600
New +$1.78M 0.08% 109

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Fosun International's ATRS Position: Q3 2019 in Review

Fosun International sold out of Antares Pharma, Inc. (ATRS) in Q3 2019, closing a stake of 809,378 shares — an estimated $2.57M sold.

Fosun International first reported a position in ATRS in Q4 2018 and held it in 3 quarters. The position peaked at $2.57M in Q2 2019. 135 funds tracked by Wall St. Rank hold ATRS as of Q3 2019.

  • Fosun International reported no remaining Antares Pharma, Inc. position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 809,378 Antares Pharma, Inc. shares in Q3 2019, an estimated $2.57M.
  • Fosun International first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 3 quarters.
  • Fosun International's Antares Pharma, Inc. position peaked at $2.57M in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.